Found: 19
Select item for more details and to access through your institution.
Therapeutic anti‐amyloid β antibodies cause neuronal disturbances.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2479, doi. 10.1002/alz.12833
- By:
- Publication type:
- Article
Cross-Linking Cellular Prion Protein Induces Neuronal Type 2-Like Hypersensitivity.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.639008
- By:
- Publication type:
- Article
Detection of retinal and blood Aβ oligomers with nanobodies.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12193
- By:
- Publication type:
- Article
Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-58524-3
- By:
- Publication type:
- Article
Plant poisoning leads to alpha-synucleinopathy and neuromelanopathy in kangaroos.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53396-8
- By:
- Publication type:
- Article
A Comparative Review of Mixed Mammary Tumors in Mammals.
- Published in:
- Journal of Mammary Gland Biology & Neoplasia, 2019, v. 24, n. 2, p. 125, doi. 10.1007/s10911-018-9422-2
- By:
- Publication type:
- Article
Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. 1, doi. 10.3389/fnagi.2018.00007
- By:
- Publication type:
- Article
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
- Published in:
- Frontiers in Neurology, 2014, v. 5, p. 1, doi. 10.3389/fneur.2014.00251
- By:
- Publication type:
- Article
PrP<sup>Sc</sup>-Specific Antibodies with the Ability to Immunodetect Prion Oligomers.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019998
- By:
- Publication type:
- Article
Polyunsaturated Fatty Acids Protect Against Prion-Mediated Synapse Damage In Vitro.
- Published in:
- Neurotoxicity Research, 2010, v. 17, n. 3, p. 203, doi. 10.1007/s12640-009-9093-2
- By:
- Publication type:
- Article
A Camelid Anti-PrP Antibody Abrogates PrP<sup>Sc</sup> Replication in Prion-Permissive Neuroblastoma Cell Lines.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009804
- By:
- Publication type:
- Article
Phospholipase A<sub>2</sub> inhibitors protect against prion and Aβ mediated synapse degeneration.
- Published in:
- Molecular Neurodegeneration, 2010, v. 5, p. 13, doi. 10.1186/1750-1326-5-13
- By:
- Publication type:
- Article
Glimepiride Reduces the Expression of PrP<sup>C</sup>, Prevents PrP<sup>Sc</sup> Formation and Protects against Prion Mediated Neurotoxicity.
- Published in:
- PLoS ONE, 2009, v. 4, n. 12, p. 1, doi. 10.1371/journal.pone.0008221
- By:
- Publication type:
- Article
Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
- Published in:
- BMC Biology, 2008, v. 6, p. 1, doi. 10.1186/1741-7007-6-39
- By:
- Publication type:
- Article
Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A<sub>2</sub> activation.
- Published in:
- BMC Biology, 2008, v. 6, p. 1, doi. 10.1186/1741-7007-6-8
- By:
- Publication type:
- Article
Ginkgolides protect against amyloid-β<sub>1-42</sub>-mediated synapse damage in vitro.
- Published in:
- Molecular Neurodegeneration, 2008, v. 3, p. 1, doi. 10.1186/1750-1326-3-1
- By:
- Publication type:
- Article
Regional heterogeneity of cellular prion protein isoforms in the mouse brain.
- Published in:
- Brain: A Journal of Neurology, 2003, v. 126, n. 9, p. 2065, doi. 10.1093/brain/awg205
- By:
- Publication type:
- Article
Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
- Published in:
- Nature, 2003, v. 422, n. 6927, p. 80, doi. 10.1038/nature01457
- By:
- Publication type:
- Article